Heparin Dosing During Percutaneous Coronary Intervention and Obesity. Kreutz RP, Leon IG, Bain ER, George B, et al. J Cardiovasc Pharmacol 2023 Dec 12. doi: 10.1097/FJC.0000000000001525.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kreutz RP, Leon IG, Bain ER, George B, et al. Heparin Dosing During Percutaneous Coronary Intervention and Obesity. J Cardiovasc Pharmacol 2023 Dec 12. doi: 10.1097/FJC.0000000000001525.
PMID: 38086077